We identified that miR-33-5p inhibits JNK signaling pathway via targeting JNK1 to repress MG-induced inflammation and apoptosis, and Lnc90386 as a ceRNA to alleviate the effect of miR-33-5p on negatively regulating JNK1 in MG infection. Here, MAPK8 is linked to myasthenia gravis.